180 related articles for article (PubMed ID: 7518713)
1. The interferons in haematological malignancies.
Mandelli F; Arcese W; Avvisati G
Baillieres Clin Haematol; 1994 Mar; 7(1):91-113. PubMed ID: 7518713
[TBL] [Abstract][Full Text] [Related]
2. [Interferon therapy in hematologic neoplasms].
Schwarzinger I; Bettelheim P; Lechner K
Wien Klin Wochenschr; 1988 Aug; 100(15):497-504. PubMed ID: 2459854
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
4. [Interferon in the therapy of hemoblastoses (a review)].
Iavorkovskiĭ LI; Iavorkovskiĭ LL
Ter Arkh; 1989; 61(10):33-9. PubMed ID: 2481891
[No Abstract] [Full Text] [Related]
5. [Interferons, a class of cytokines with a large therapeutic activity range].
Billard C
Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases.
Manoharan A; Catovsky D; Clein P; Traub NE; Costello C; O'Brien M; Boralessa H; Galton DA
Br J Haematol; 1981 May; 48(1):111-6. PubMed ID: 6941808
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
Jakó J; Szerafin L
Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies.
Grandér D; Xu B; Einhorn S
Eur J Cancer; 1993; 29A(14):1940-3. PubMed ID: 7506559
[TBL] [Abstract][Full Text] [Related]
9. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
[TBL] [Abstract][Full Text] [Related]
10. Interferons for the treatment of hematological malignancies.
Urabe A
Oncology; 1994; 51(2):137-41. PubMed ID: 7515169
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress in Interferon Therapy for Myeloid Malignancies.
Healy FM; Dahal LN; Jones JRE; Floisand Y; Woolley JF
Front Oncol; 2021; 11():769628. PubMed ID: 34778087
[TBL] [Abstract][Full Text] [Related]
12. Interferon: cellular executioner or white knight?
Maher SG; Romero-Weaver AL; Scarzello AJ; Gamero AM
Curr Med Chem; 2007; 14(12):1279-89. PubMed ID: 17504213
[TBL] [Abstract][Full Text] [Related]
13. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
14. Interferon therapy for lymphoproliferative disorders.
Roth MS; Bunn PA; Foon KA
Cancer Treat Res; 1988; 38():231-52. PubMed ID: 2484433
[No Abstract] [Full Text] [Related]
15. General principles of treatment.
Schouten HC
Ann Oncol; 2007 Jan; 18 Suppl 1():i29-i32. PubMed ID: 17311818
[No Abstract] [Full Text] [Related]
16. Biotherapy in clinical practice.
Figlin RA
Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
[TBL] [Abstract][Full Text] [Related]
17. [Interferon-alpha in the treatment of myeloproliferative syndromes].
Ballarino P; Castello G; Lerza R
Recenti Prog Med; 1994 Nov; 85(11):546-50. PubMed ID: 7855389
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-interferon on serum beta-2-microglobulin.
Remes K; Tienhaara A; Pelliniemi TT
Leuk Lymphoma; 1996 Apr; 21(3-4):233-8. PubMed ID: 8726404
[TBL] [Abstract][Full Text] [Related]
19. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
20. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
